These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 28210808)

  • 21. Dose-response evaluation of levalbuterol versus racemic albuterol in patients with asthma.
    Handley DA; Tinkelman D; Noonan M; Rollins TE; Snider ME; Caron J
    J Asthma; 2000 Jun; 37(4):319-27. PubMed ID: 10883742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study.
    Donohue JF; Hanania NA; Ciubotaru RL; Noe L; Pasta DJ; Schaefer K; Claus R; Andrews WT; Roach J
    Clin Ther; 2008; 30 Spec No():989-1002. PubMed ID: 18640474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A patient satisfaction survey comparing levalbuterol with racemic albuterol in children.
    Berger WE; Ames DE; Harrison D
    Allergy Asthma Proc; 2004; 25(6):437-44. PubMed ID: 15709455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A preliminary comparison of levalbuterol and albuterol in prehospital care.
    Thompson M; Wise S; Rodenberg H
    J Emerg Med; 2004 Apr; 26(3):271-7. PubMed ID: 15028323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The asthma-like pharmacology and toxicology of (S)-isomers of beta agonists.
    Handley D
    J Allergy Clin Immunol; 1999 Aug; 104(2 Pt 2):S69-76. PubMed ID: 10452791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical outcomes of levalbuterol versus racemic albuterol in pediatric patients with asthma: Propensity score matching approach in a medicaid population.
    Yuan J; Lu ZK; Zhang Y; Wu J; Love BL; Schulz RM
    Pediatr Pulmonol; 2017 Apr; 52(4):516-523. PubMed ID: 27701831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single-isomer levalbuterol: a review of the acute data.
    Nowak R
    Curr Allergy Asthma Rep; 2003 Mar; 3(2):172-8. PubMed ID: 12562558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of racemic albuterol and levalbuterol for treatment of acute asthma.
    Carl JC; Myers TR; Kirchner HL; Kercsmar CM
    J Pediatr; 2003 Dec; 143(6):731-6. PubMed ID: 14657817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Levalbuterol in the treatment of patients with asthma and chronic obstructive lung disease.
    Dalonzo GE
    J Am Osteopath Assoc; 2004 Jul; 104(7):288-93. PubMed ID: 15293593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of an inhaled β2-agonist on cardiovascular function and sympathetic activity in healthy subjects.
    Snyder EM; Wong EC; Foxx-Lupo WT; Wheatley CM; Cassuto NA; Patanwala AE
    Pharmacotherapy; 2011 Aug; 31(8):748-56. PubMed ID: 21923601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Levalbuterol versus albuterol.
    Ameredes BT; Calhoun WJ
    Curr Allergy Asthma Rep; 2009 Sep; 9(5):401-9. PubMed ID: 19671384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levalbuterol nebulizer solution: is it worth five times the cost of albuterol?
    Asmus MJ; Hendeles L
    Pharmacotherapy; 2000 Feb; 20(2):123-9. PubMed ID: 10678290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term safety study of levalbuterol administered via metered-dose inhaler in patients with asthma.
    Hamilos DL; D'Urzo A; Levy RJ; Marcus M; Tripp K; Parsey M; Baumgartner RA; McVicar WK
    Ann Allergy Asthma Immunol; 2007 Dec; 99(6):540-8. PubMed ID: 18219836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Population pharmacokinetics of (R)-albuterol and (S)-albuterol in pediatric patients aged 4-11 years with asthma.
    Maier G; Rubino C; Hsu R; Grasela T; Baumgartner RA
    Pulm Pharmacol Ther; 2007; 20(5):534-42. PubMed ID: 16891136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Levalbuterol kinetics.
    Lipworth BJ; Clearie K
    J Allergy Clin Immunol; 2009 Jan; 123(1):275. PubMed ID: 19130946
    [No Abstract]   [Full Text] [Related]  

  • 36. Low-dose levalbuterol in children with asthma: safety and efficacy in comparison with placebo and racemic albuterol.
    Milgrom H; Skoner DP; Bensch G; Kim KT; Claus R; Baumgartner RA;
    J Allergy Clin Immunol; 2001 Dec; 108(6):938-45. PubMed ID: 11742271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spiroergometric parameters at maximal exercise testing assessed functional respiratory impairment in asbestos-induced fibrosis.
    Schneider J; Arhelger R; Funk M
    Clin Respir J; 2014 Apr; 8(2):175-84. PubMed ID: 24028216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical outcomes and treatment cost comparison of levalbuterol versus albuterol in hospitalized adults with chronic obstructive pulmonary disease or asthma.
    Brunetti L; Poiani G; Dhanaliwala F; Poppiti K; Kang H; Suh DC
    Am J Health Syst Pharm; 2015 Jun; 72(12):1026-35. PubMed ID: 26025994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of racemic albuterol and levalbuterol in the treatment of acute asthma in the ED.
    Schreck DM; Babin S
    Am J Emerg Med; 2005 Nov; 23(7):842-7. PubMed ID: 16291438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of levalbuterol with racemic albuterol in the treatment of acute severe asthma exacerbations in adults.
    Nowak R; Emerman C; Hanrahan JP; Parsey MV; Hanania NA; Claus R; Schaefer K; Baumgartner RA;
    Am J Emerg Med; 2006 May; 24(3):259-67. PubMed ID: 16635694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.